Ptc Therapeutics (PTCT) Non-Current Assets (2012 - 2026)

Ptc Therapeutics' Non-Current Assets history runs 15 years deep, the most recent figure standing at $615.1 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 81.46% year-over-year to $615.1 million in Q1 2026; TTM through Mar 2026 was $2.2 billion, a 24.45% increase from a year earlier, with the FY2025 full-year figure at $624.8 million, up 84.04% from the prior year.
• Non-Current Assets fell to $615.1 million in Q1 2026 per PTCT's latest filing, from $624.8 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.1 billion in Q2 2022 and bottomed at $339.0 million in Q1 2025.
• The 5-year median for Non-Current Assets is $635.9 million (2025), against an average of $706.0 million.
• Across the five-year window, Non-Current Assets plunged 49.86% in 2024 and jumped 84.04% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $1.0 billion in 2022, then slumped by 33.08% to $677.1 million in 2023, then plunged by 49.86% to $339.5 million in 2024, then jumped by 84.04% to $624.8 million in 2025, then dropped by 1.56% to $615.1 million in 2026.
• Per Business Quant, the three latest PTCT Non-Current Assets figures stand at $615.1 million (Q1 2026), $624.8 million (Q4 2025), and $635.9 million (Q3 2025).